SET antagonist enhances the chemosensitivity of non-small cell lung cancer cells by reactivating protein phosphatase 2A. [electronic resource]
Producer: 20161107Description: 638-55 p. digitalISSN:- 1949-2553
- Aged
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- DNA-Binding Proteins
- Disease-Free Survival
- Drug Synergism
- Enzyme Activation -- drug effects
- Female
- Histone Chaperones -- antagonists & inhibitors
- Humans
- Immunohistochemistry
- Lung Neoplasms -- drug therapy
- Male
- Mice, Nude
- Middle Aged
- Paclitaxel -- administration & dosage
- Protein Phosphatase 2 -- metabolism
- Proto-Oncogene Proteins c-akt -- metabolism
- Quinazolines -- administration & dosage
- RNA Interference
- Reverse Transcriptase Polymerase Chain Reaction
- Transcription Factors -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.